Correlation Between Coeptis Therapeutics and Clearmind Medicine

Can any of the company-specific risk be diversified away by investing in both Coeptis Therapeutics and Clearmind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coeptis Therapeutics and Clearmind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coeptis Therapeutics and Clearmind Medicine Common, you can compare the effects of market volatilities on Coeptis Therapeutics and Clearmind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coeptis Therapeutics with a short position of Clearmind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coeptis Therapeutics and Clearmind Medicine.

Diversification Opportunities for Coeptis Therapeutics and Clearmind Medicine

0.36

Correlation Coefficient

Coeptis Therapeutics  Clearmind Medicine

Weak diversification

The 3 months correlation between Coeptis and Clearmind is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Coeptis Therapeutics and Clearmind Medicine Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearmind Medicine Common and Coeptis Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coeptis Therapeutics are associated (or correlated) with Clearmind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearmind Medicine Common has no effect on the direction of Coeptis Therapeutics i.e., Coeptis Therapeutics and Clearmind Medicine go up and down completely randomly.

Pair Corralation between Coeptis Therapeutics and Clearmind Medicine

Given the investment horizon of 90 days Coeptis Therapeutics is expected to generate 5.35 times more return on investment than Clearmind Medicine. However, Coeptis Therapeutics is 5.35 times more volatile than Clearmind Medicine Common. It trades about 0.31 of its potential returns per unit of risk. Clearmind Medicine Common is currently generating about -0.05 per unit of risk. If you would invest  422.00  in Coeptis Therapeutics on October 26, 2024 and sell it today you would earn a total of  552.00  from holding Coeptis Therapeutics or generate 130.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Coeptis Therapeutics  vs.  Clearmind Medicine Common

Coeptis Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Coeptis Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain technical and fundamental indicators, Coeptis Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Clearmind Medicine Common

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearmind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Coeptis Therapeutics and Clearmind Medicine

The main advantage of trading using opposite Coeptis Therapeutics and Clearmind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coeptis Therapeutics position performs unexpectedly, Clearmind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearmind Medicine will offset losses from the drop in Clearmind Medicine's long position.

The idea behind Coeptis Therapeutics and Clearmind Medicine Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.